AKZOINDIA2024-04-012024-06-30 AKZOINDIA2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member AKZOINDIA2024-06-30 AKZOINDIA2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue01Member AKZOINDIA2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults01Member AKZOINDIA2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets01Member AKZOINDIA2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member AKZOINDIA2024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member AKZOINDIA2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500710 AKZOINDIA NOTLISTED Akzo Nobel India Limited Equity 2024-04-01 2025-03-31 2024-08-01 2024-07-11 INR Millions First quarter 10:45:00 11:40:00 2024-08-01 2024-08-01 Not applicable Geographical 2024-04-01 2024-06-30 Unaudited Consolidated 10362741000.00 96989000.00 10459730000.00 5289946000.00 540543000.00 -93900000.00 886188000.00 24672000.00 218079000.00 2051366000.00 8916894000.00 1542836000.00 0.00 1542836000.00 418532000.00 -21805000.00 396727000.00 0.00 1146109000.00 0.00 0.00 0.00 0.00 1146109000.00 -6851000.00 1139258000.00 0.00 0.00 0.00 0.00 455400000.00 10 25.17 25.17 0.00 0.00 25.17 25.17 Notes to the Statement of Consolidated Unaudited Financial Results for the quarter ended 30 June 2024 1. The Statement of Consolidated Unaudited Financial Results has been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 01 August 2024. The figures for the quarter ended 30 June 2024 have been subjected to limited review by the statutory auditors. 2. The figures for the quarter ended 31 March 2024 have not been subjected to review/audit by the statutory auditors. These are balancing figures between Consolidated Audited Financial Statements for the financial year ended 31 March 2024 and year to date Consolidated Unaudited Financial Results for the nine months period ended 31 December 2023. 3. The Consolidated Unaudited Financial Results include the results of the following entities namely, Akzo Nobel India Limited (Parent) and ICI India Research and Technology Centre Private Limited (Formerly known as ICI India Research and Technology Centre) (Subsidiary), hereinafter referred to as the Group. 4. The Group is principally engaged in the business of manufacturing paints, coatings and allied products in India with similar risk, returns and internal business reporting system. Accordingly, there are no reportable segment(s) other than Paints , which singly or in aggregate qualify for separate disclosure as per provisions of the relevant lnd AS 108 Operating segments”. Gurugram Rajiv Rajgopal 01 August 2024 Other Expenses 2051366000.00 Paints 10362741000.00 10362741000.00 0.00 10362741000.00 Paints 1567508000.00 1567508000.00 24672000.00 1542836000.00 Paints 29039306000.00 29039306000.00 Paints 29039306000.00 29039306000.00 Gain/(Loss) of defined benefit plans -9155000.00 -9155000.00 -2304000.00